( NASDAQ-NMS:LXRX )

News from lexicon pharmaceuticals, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Apr 29, 2016, 16:05 ET Lexicon To Report First Quarter 2016 Financial Results On May 3, 2016

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) will release its first quarter 2016 financial results on Tuesday, May 3, 2016 before the...


Apr 07, 2016, 16:01 ET Lexicon To Present At The 15th Annual Needham Healthcare Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the 15th Annual Needham Healthcare...


Mar 30, 2016, 17:02 ET Lexicon Submits New Drug Application To FDA For Telotristat Etiprate For The Treatment Of Carcinoid Syndrome

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it has submitted a New Drug Application to the U.S. Food and Drug...


Mar 08, 2016, 08:00 ET Lexicon Announces Telotristat Etiprate Data To Be Presented At European Neuroendocrine Tumor Society Conference

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that data from the open label extension of its TELESTAR Phase 3 clinical study of...


Mar 03, 2016, 17:00 ET Lexicon To Present At The 36th Annual Cowen Healthcare Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the 36th Annual Cowen Healthcare...


Mar 01, 2016, 07:00 ET Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2015 Fourth Quarter And Full Year Financial Results

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the three months and year ended December 31, 2015 and...


Feb 25, 2016, 08:00 ET Lexicon To Report Fourth Quarter And Year End 2015 Financial Results On March 1, 2016

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) will release its fourth quarter and year end 2015 financial results on Tuesday, March 1, 2016...


Jan 07, 2016, 08:00 ET Lexicon To Present At The 34th Annual J.P. Morgan Healthcare Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the 34th Annual J.P. Morgan Healthcare...


Dec 07, 2015, 07:00 ET Lexicon To Present At The Oppenheimer 26th Annual Healthcare Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the Oppenheimer 26th Annual Healthcare...


Dec 01, 2015, 08:07 ET Telotristat Etiprate Achieves Positive Top-Line Results In Second Phase 3 Clinical Trial

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX)  announced today that top-line data from its TELECAST Phase 3 study showed results of...


Nov 12, 2015, 08:00 ET Lexicon To Present At The Stifel 2015 Healthcare Conference And The Jefferies 2015 Global Healthcare Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the Stifel 2015 Healthcare Conference on...


Nov 06, 2015, 06:00 ET Lexicon Pharmaceuticals Reports 3rd Quarter Financial Results And Discusses Collaboration With Sanofi For Sotagliflozin

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the third quarter ended September 30, 2015 and provided an...


Nov 06, 2015, 01:01 ET Sanofi and Lexicon Pharmaceuticals to Collaborate on Sotagliflozin, an Investigational New Oral Medicine for People with Diabetes

 Sanofi (EURONEXT: SAN and NYSE: SNY) and Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) announced today that they have entered into a...


Nov 05, 2015, 16:01 ET Lexicon To Report Third Quarter 2015 Financial Results On November 6, 2015

Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) will release its third quarter 2015 financial results on Friday, November 6, 2015 before the financial...


Oct 19, 2015, 07:00 ET Cancer Patients Treated With Lexicon's Telotristat Etiprate Report Improved Function And Well-Being

 Lexicon Pharmaceuticals, Inc.'s (Nasdaq: LXRX) telotristat etiprate, the first oral therapy in development for the treatment of carcinoid...


Oct 09, 2015, 08:00 ET Lexicon Announces Telotristat Etiprate Data To Be Presented At North American Neuroendocrine Tumor Society Annual Symposium

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that data from the TELESTAR Phase 3 clinical study of telotristat etiprate has...


Sep 29, 2015, 06:00 ET Lexicon's Telotristat Etiprate Shows Clinical Benefit In Treating Carcinoid Syndrome In Cancer Patients When Added To Standard Of Care

 Lexicon Pharmaceuticals, Inc.'s (Nasdaq: LXRX)  telotristat etiprate was shown to have clinical benefit in treating carcinoid syndrome in...


Sep 28, 2015, 08:00 ET Media Alert: Lexicon To Discuss Complete Results Of Pivotal Phase 3 TELESTAR Study

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced it will hold a conference call and webcast to discuss complete results of...


Sep 08, 2015, 07:00 ET Lexicon Announces Sotagliflozin Data To Be Presented At European Association For The Study Of Diabetes

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that data from its Phase 2 clinical study of sotagliflozin in type 1 diabetes...


Aug 26, 2015, 08:00 ET Lexicon Announces Telotristat Etiprate Data To Be Presented At European Cancer Congress

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that data from its pivotal TELESTAR Phase 3 clinical study of telotristat...


Aug 10, 2015, 17:00 ET Lexicon To Present At The 2015 Wedbush PacGrow Healthcare Conference

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced today that Lexicon management will present at the 2015 Wedbush PacGrow Healthcare...


Aug 07, 2015, 07:00 ET Lexicon Pharmaceuticals Reports 2nd Quarter Financial Results, Provides Clinical Pipeline Update

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the second quarter ended June 30, 2015 and provided an...


Aug 05, 2015, 17:00 ET Lexicon to Report Second Quarter 2015 Financial Results on August 7, 2015

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) will release its second quarter 2015 financial results on Friday, August 7, 2015 before the...


Aug 03, 2015, 01:01 ET Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the pivotal TELESTAR Phase 3 clinical trial met its primary endpoint,...


Jun 06, 2015, 12:01 ET Lexicon Announces Presentation Of Manuscript At The American Diabetes Association Diabetes Care Symposium

 Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced that the manuscript entitled "Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as...